MIM
AGN

MetLife Investment Management’s Allergan plc AGN Stock Holding History

MetLife Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-84,618
Closed -$15M – 2406
2020
Q1 		$15M Sell
84,618
-2,589
-3% -$487K 0.2% 94
2019
Q4 		$16.7M Sell
87,207
-2,063
-2% -$372K 0.17% 111
2019
Q3 		$15M Buy
89,270
+4,336
+5% +$706K 0.17% 114
2019
Q2 		$14.2M Sell
84,934
-3,979
-4% -$551K 0.15% 121
2019
Q1 		$13M Sell
88,913
-1,787
-2% -$259K 0.14% 131
2018
Q4 		$12.1M Sell
90,700
-2,149
-2% -$352K 0.15% 130
2018
Q3 		$17.7M Buy
+92,849
New +$17.1M 0.18% 101

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

MetLife Investment Management's AGN Position: Q2 2020 in Review

MetLife Investment Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 84,618 shares — an estimated $15M sold.

MetLife Investment Management first reported a position in AGN in Q3 2018 and held it in 7 quarters. The position peaked at $17.7M in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • MetLife Investment Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • MetLife Investment Management sold 84,618 Allergan plc shares in Q2 2020, an estimated $15M.
  • MetLife Investment Management first reported a position in Allergan plc in Q3 2018 and held it in 7 quarters.
  • MetLife Investment Management's Allergan plc position peaked at $17.7M in Q3 2018.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on MetLife Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.